|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 76.50 USD | -0.64% |
|
-0.86% | +24.33% |
| 09-14 | Livanova Insider Sold Shares Worth $273,032, According to a Recent SEC Filing | MT |
| 09-14 | LivaNova PLC Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 11:30 AM |
Company Valuation: LivaNova PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,654 | 2,973 | 2,787 | 2,515 | 3,360 | 4,215 | - | - |
| Change | - | -36.12% | -6.24% | -9.78% | 33.61% | 25.44% | - | - |
| Enterprise Value (EV) 1 | 4,685 | 2,973 | 2,796 | 2,419 | 3,101 | 4,290 | 4,130 | 3,942 |
| Change | - | -36.55% | -5.94% | -13.49% | 28.21% | 38.33% | -3.73% | -4.55% |
| P/E | -32.6x | -34.5x | 162x | 39.9x | -13.8x | 19.1x | 23.1x | 20x |
| PBR | 3.6x | - | 2.18x | 1.91x | - | - | - | - |
| PEG | - | 0.9x | -1x | 0x | 0x | -0x | -1.4x | 1.3x |
| Capitalization / Revenue | 4.49x | 2.91x | 2.42x | 2.01x | 2.42x | 2.77x | 2.59x | 2.42x |
| EV / Revenue | 4.52x | 2.91x | 2.42x | 1.93x | 2.23x | 2.82x | 2.53x | 2.26x |
| EV / EBITDA | 26.1x | 17.7x | 14.4x | 9.15x | 9.85x | 12.6x | 11.2x | 9.79x |
| EV / EBIT | 30.3x | 20.5x | 16.5x | 10.1x | 10.8x | 13.4x | 11.8x | 10.1x |
| EV / FCF | - | 68.5x | 70.1x | - | 17.9x | -81.6x | 20.2x | 15.3x |
| FCF Yield | - | 1.46% | 1.43% | - | 5.59% | -1.23% | 4.94% | 6.56% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.68 | -1.61 | 0.32 | 1.16 | -4.45 | 3.997 | 3.319 | 3.832 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,035 | 1,022 | 1,154 | 1,253 | 1,388 | 1,522 | 1,630 | 1,745 |
| EBITDA 1 | 179.3 | 167.5 | 194 | 264.3 | 314.7 | 341.1 | 369.4 | 402.8 |
| EBIT 1 | 154.8 | 145.1 | 169.3 | 239.2 | 286.1 | 320 | 348.6 | 389.3 |
| Net income 1 | -135.8 | -86.2 | 17.5 | 63.2 | -242.5 | 226.2 | 186.9 | 218 |
| Net Debt 1 | 31.53 | - | 8.7 | -96 | -258.9 | 75 | -85 | -273 |
| Reference price 2 | 87.43 | 55.54 | 51.74 | 46.31 | 61.53 | 76.50 | 76.50 | 76.50 |
| Nbr of stocks (in thousands) | 53,225 | 53,523 | 53,871 | 54,301 | 54,606 | 55,094 | - | - |
| Announcement Date | 2/23/22 | 2/22/23 | 2/21/24 | 2/25/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.14x | 2.82x | 12.58x | - | 4.21B | |
| 28x | 3.88x | 15.01x | 2.6% | 171B | |
| 18.25x | 3.37x | 12.03x | 3.26% | 110B | |
| 21.42x | 4.21x | 14.72x | 1.31% | 106B | |
| 25.75x | 2.52x | 10.21x | 2.8% | 75.99B | |
| 16.44x | 0.19x | 12.1x | 0.79% | 57.3B | |
| 34.49x | 3.36x | 11.49x | 2.19% | 48.76B | |
| 28.75x | 7.1x | 18.34x | 1.39% | 50.19B | |
| 35.36x | 8.79x | 24.72x | -.--% | 41.14B | |
| 34.67x | 6.08x | 19.09x | -.--% | 32.56B | |
| Average | 26.23x | 4.23x | 15.03x | 1.59% | 69.72B | |
| Weighted average by Cap. | 25.47x | 3.98x | 14.47x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LIVN Stock
- Valuation LivaNova PLC
Select your edition
All financial news and data tailored to specific country editions
